Merck and Wayra to tackle NHS funding gap with startup rewards programme
September 25, 2015Research and Development MSD, Merck
Merck Sharpe and Dohme (MSD) and Wayra Open Future, Telefonica’s digital start up accelerator, are investing in digital innovation in …
ABPI responds to UK medicines cost controversy
September 25, 2015Medical Communications, Sales and Marketing ABPI, Cancer Drugs Fund, NHS
Alison Clough, acting CEO of the Association of the British Pharmaceutical Industry (ABPI), has responded to recent reports in the …
Genetic study reveals new associations with lung disease and smoking behaviour
September 25, 2015Medical Communications, Research and Development COPD, lung cancer, smkoing
New research published in The Lancet Respiratory Medicine and presented at this year’s European Respiratory Society (ERS) Congress in Amsterdam …
Novartis launches affordable medicines portfolio for lower-income countries
September 24, 2015Manufacturing and Production, Sales and Marketing Novartis
Novartis has announced the launch of ‘Novartis Access’, a portfolio of 15 medicines to treat chronic diseases in low and …
NICE approves first in new class of leukaemia drugs
September 24, 2015Cancer Drugs Fund, Gilead Sciences, NHS, NICE, idelalisib, leukaemia, zydelig
NICE has issued final draft guidance which recommends that Gilead’s Zydelig should be made available on the NHS for some …
Turing will drop price of Daraprim following outrage
September 24, 2015Sales and Marketing Daraprim, Impax Laboratories, Martin Shkreli, Turing Pharmaceuticals, toxoplasmosis
Martin Shkreli, whose company Turing Pharmaceuticals increased the price of Daraprim more than fifty-fold overnight, has been forced to backpedal …
Boehringer and BioMed X crowdsource top scientists to fight COPD
September 23, 2015Research and Development Boehringer Ingelheim, COPD
Boehringer Ingelheim and BioMed X have used a crowdsourcing strategy to establish a global research team to collaborate on the …
ViiV in late-stage HIV trial success
September 23, 2015Research and Development HIV, Triumeq, ViiV, virology
Switching patients to Triumeq, a once-daily combination treatment for HIV, is as effective as remaining on antiretroviral therapy in certain …
Pharma ‘is getting better at drug R&D’
September 23, 2015Research and Development R&D, drug development, market access, productivity
An investigation into pharma R&D data shows that drugmakers are becoming more successful at identifying the right candidates for drug …
Novo Nordisk to build manufacturing plant for FlexPen in Iran
September 22, 2015Manufacturing and Production Iran, Novo Nordisk, diabetes
Novo Nordisk has announced that Novo Nordisk Iran and the Food and Drug Administration of the Islamic Republic of Iran …
Anger as drug price rises from $13.50 to $750 overnight
September 22, 2015Manufacturing and Production, Sales and Marketing pyrimethamine, turing
Turing founder Martin Shkreli has been forced to defend the company’s decision to raise the price of the drug Daraprim …
Vision for hi-tech manufacturing in the Scottish highlands
September 22, 2015Manufacturing and Production, Research and Development GSK, Scotland, manufacturing
Scottish life and chemical science firms claim Scotland is an ideal European base for UK and global manufacturers. A new …
Pfizer and GSK in antidepressant safety probes
September 22, 2015Manufacturing and Production GSK, Paxil, Pfizer, Zoloft, antidepressants, drug safety, paroxetine, sertraline
Two top-selling antidepressants have had their safety records challenges, after the FDA asked Pfizer to change the labelling of its …
Featured market report: Cancer diagnostics market – Forecast to 2020
September 22, 2015Manufacturing and Production, Sales and Marketing cancer diagnostics, market report, marketsandmarkets
The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms.Moreover, the market …
Shire ADHD treatment Intuniv gets EU approval
September 21, 2015Sales and Marketing ADHD, Shire, attention deficit hyperactivity disorder, intuniv
The European Commission has granted marketing authorisation for Shire’s Intuniv for the treatment of ADHD in children. Intuniv (guanfacine hydrochloride prolonged …
Working Life: Novo Nordisk’s Klaus Henning-Jensen
September 21, 2015Sales and Marketing Novo Nordisk, Working Life
How did you find your way into your current role?I started out in medicine at Bispebjerg, which is a large …
Amgen’s Kyprolis gets accelerated FDA review for expanded labelling
September 21, 2015Sales and Marketing Amgen, FDA, Kyprolis, carfilzomib, multiple myeloma
The FDA has accepted for priority review Amgen’s supplemental new drug application for Kyprolis (carfilzomib) for patients with relapsed multiple …
Roche to present new Esbriet data at ERS Congress 2015
September 21, 2015Research and Development, Sales and Marketing Esbriet, European Respiratory Congress, Roche, idiopathic pulmonary fibrosis, pirfenidone
Roche has announced it will present new data analyses of Esbriet in idiopathic pulmonary fibrosis (IPF) at the European Respiratory …
More positive CV data for Boehringer and Lilly’s Jardiance
September 21, 2015Research and Development, Sales and Marketing Boehringer Ingelheim, EASD, Eli Lilly, cardiovascular risk, empagliflozin, jardiance, mortality risk, type 2 diabetes
Jardiance, an anti-diabetes drug produced by Boehringer Ingelheim and Eli Lilly, reduces the risk of death in people with type …
Biocair opens new site in Belgium
September 21, 2015Research and Development, Sales and Marketing Biocair
Biocair is pleased to announce the opening of its new premises in Belgium. The new state of the art facility …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
